Madrigal Pharmaceuticals Presents Phase 3 MAESTRO-NASH Data During the Opening…
First scientific presentation of detailed MAESTRO-NASH results confirms achievement of primary endpoints across multiple patient subgroupsNoninvasive imaging and biomarker data support…